Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,855.8
-1.7 (-0.06%)

 

  • STI Straits Times Index
    2,855.8
    -1.7 (-0.06%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,607.6
    -4.5 (-0.28%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,894.7
    75.2 (0.28%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,408.3
    38.6 (1.14%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    26,644.7
    107.4 (0.40%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,783.3
    23.4 (0.41%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,405.7M
  • Value: 1,046.1M
  • Rise: 173
  • Fall: 135
  • Unch: 466

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Alset0.083+0.019
Oceanus^0.025-0.002
Jiutian Chemical0.088+0.001
Sembcorp Marine0.168-0.001
Intl Cement0.071+0.002
QT Vascular0.007-
Broadway Ind0.163+0.006
YZJ Shipbldg SGD0.920-0.010
ThaiBev0.750+0.005
Adventus0.027-

World Indices

World Indices
Name Last Change
Nasdaq 12,094.4 +57.6
HSI 26,894.7 +75.2
HSCEI 10,790.3 +88.8
Jakarta 5,783.3 +23.4
Nikkei 225 26,644.7 +107.4
SSE Comp 3,408.3 +38.6
Shanghai A 3,572.4 +40.5
Shanghai B 244.7 -1.3
KOSPI 2,633.4 +7.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ENOCHIAN BIOSCIENCES INC ENOCHIAN BIOSCIENCES
Updated on 27 Nov 2020 (End of trading day)
Last (USD): 2.820 Change: -0.160 High: 3.011 Remarks: -
Change (%): -5.37 Low: 2.600
Open 2.990 Yesterday's Close 2.98
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 309,380 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.24479 Trailing EPS (USD) e -0.20863 NAV (USD) b 3.5215
PE a - Trailing PE f - Price / NAV b 0.8008
Dividend (USD) d - Cash In Hand (USD) g 0.1279 Issued & Paid-up Shares c 46,637,000
Dividend Yield (%) d - Price / Cash In Hand g 22.048 Treasury Shares h -
Market Cap (M) 131.516 Enterprise Value (M) 133.142
Piotroski F Score 0 Exchange Code ENOB Par Value ( $ ) n.a.
52 Weeks Volatility (%) 70.31 Free Float (%) 28.2
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 25 Sep 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 10 Dec 2018.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ENOCHIAN BIOSCIENCES INC NASDAQ 131.516 - - 0.8008 -
Industry Biotechnology NASDAQ 2,815.140 458.260 - 6.5922 0.612
Local Peer AMGEN INC NASDAQ 130,877.413 16.689 17.802 11.9425 2.621
Local Peer GILEAD SCIENCES INC NASDAQ 75,249.406 13.971 59.345 4.3135 4.240
Local Peer VERTEX PHARMACEUTICAL NASDAQ 58,953.215 50.096 21.910 7.2482 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 54,852.204 25.925 17.380 5.4172 -
Local Peer ILLUMINA INC NASDAQ 46,286.380 46.194 72.549 9.8482 -
Local Peer MODERNA INC NASDAQ 50,267.041 - - 18.2140 -
Local Peer BIOGEN INC NASDAQ 37,513.354 6.371 7.381 3.4869 -
Local Peer SEAGEN INC NASDAQ 30,493.351 - 64.549 13.5044 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 27,099.576 11.271 28.329 2.4469 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 26,196.648 - - 24.0810 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 25,910.782 - - 6.0433 -
Local Peer 10X GENOMICS INC NASDAQ 23,812.595 - - 28.8612 -
Other Local Peers EXACT SCIENCES CORP (NASDAQ), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), BIO-TECHNE CORP (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), KODIAK SCIENCES INC (NASDAQ), NOVAVAX INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), INSMED INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), FIBROGEN INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), ALKERMES PLC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ALLOVIR INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), UNIQURE N.V. (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), VAXCYTE INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), SHATTUCK LABS INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), CORTEXYME INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), PRECIGEN INC (NASDAQ), REGENXBIO INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), MACROGENICS INC (NASDAQ), EPIZYME INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), NKARTA INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), PERSONALIS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), IMMUNOGEN INC (NASDAQ), INHIBRX INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ARVINAS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), PASSAGE BIO INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), NANTKWEST INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), OMEROS CORP (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), VAXART INC (NASDAQ), KADMON HLDGS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), ANAPTYSBIO INC (NASDAQ), AGENUS INC (NASDAQ), AKOUOS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), IMMATICS N V (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), AVROBIO INC (NASDAQ), ONCORUS INC (NASDAQ), IVERIC BIO INC (NASDAQ), GERON CORP (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), ARDELYX INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ATRECA INC (NASDAQ), XBIOTECH INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), HUMANIGEN INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), UROGEN PHARMA LTD (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), PROTHENA CORP PLC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), XOMA CORP (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), ATHERSYS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), KAMADA (NASDAQ), PDL BIOPHARMA INC (NASDAQ), VERASTEM INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ADICET BIO INC (NASDAQ), IMV INC (NASDAQ), CHIMERIX INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), METACRINE INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), OTONOMY INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), CONTRAFECT CORP (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CELYAD ONCOLOGY ADS EACH REPR 1 ORD (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), EQUILLIUM INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), BIOVIE INC (NASDAQ), ORGENESIS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), IMMUNOME INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), EVOGENE LTD (NASDAQ), INFLARX N V (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), SYNLOGIC INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), COHBAR INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), SAVARA INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), SOLIGENIX INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), VACCINEX INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), PRECIPIO INC (NASDAQ), ATYR PHARMA INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), BIOCARDIA INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ADVAXIS INC (NASDAQ), HISTOGEN INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), GEOVAX LABS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ)
Global Peer CSL ASX 137,857.122 43.955 43.955 14.5410 0.969
Global Peer WUXI BIO HKEx 310,653.898 - - - -
Global Peer BEIGENE HKEx 187,206.682 - - 5.6340 -
Global Peer SINO BIOPHARM HKEx 143,158.785 46.642 52.054 4.1462 0.701
Global Peer ZAI LAB-SB HKEx 70,040.774 - - 19.4149 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 4,389.915 80.549 26.350 3.5077 -
Global Peer GENSCRIPT BIO HKEx 21,062.251 - - 2.8807 -
Global Peer 3SBIO HKEx 18,949.820 17.163 12.621 1.6200 -
Global Peer MYOVANT SCIENCES LTD NYSE 2,131.667 - - -10.6702 -
Other Global Peers ALPHAMAB-B (HKEx), MESOBLAST LTD (ASX), VIVA BIOTECH (HKEx), ARCUS BIOSCIENCES INC (NYSE), POLYNOVO LIMITED (ASX), JW THERAP-B (HKEx), JHBP-B (HKEx), HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), ASCENTAGE-B (HKEx), DPHARMA (Bursa), SQZ BIOTECHNOLOGIES CO (NYSE), TELIX PHARMACEUTIC (ASX), OPTHEA LIMITED (ASX), KINTOR PHARMA-B (HKEx), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), IMUGENE LIMITED (ASX), LEE'S PHARM (HKEx), ESSEX BIO-TECH (HKEx), NANOVIRICIDES INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), NEXT SCIENCE LTD (ASX), 22ND CENTURY GROUP INC (NYSE American), IBIO INC (NYSE American), ANTEOTECH LIMITED (ASX), KAZIA THERAPEUTICS LIMITED (ASX), IMMUTEP LTD (ASX), CEL-SCI CORP (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), ENZO BIOCHEM INC (NYSE), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), MEMPHASYS LTD (ASX), BIONOMICS LTD (ASX), AIM IMMUNOTECH INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), PALATIN TECHNOLOGIES INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), GENETIC TECHNOLOGIES (ASX), BIOTRON (ASX), REGENT PACIFIC (HKEx), RHINOMED LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), Suntar Eco-City (SGX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), CONSTELLATION TECHNOLOGIES LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), PATRYS LIMITED (ASX), ACTINOGEN MEDICAL LTD (ASX), REGENEUS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ADALTA LTD (ASX), ORAGENICS INC (NYSE American), AMPLIA THERAPEUTICS LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), HAO WEN HLDGS (HKEx), CRYOSITE (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), LEAF RESOURCES LTD (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.410
-12.69 %
10 Days --0.250
-8.14 %
20 Days --0.350
-11.04 %
Medium Term Return 3 Months --1.180
-29.50 %
6 Months --0.850
-23.16 %
1 Year --3.140
-52.68 %
Annualised Return Annualised --
-52.68 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.950 - 13.430 Change From 1 Year Low +0.870 % Change From 1 Year Low (%) +44.62
Change From 1 Year High -10.610 % Change From 1 Year High (%) -79.00
2 Years Range 1.950 - 13.430 Change From 2 Years Low +0.870 % Change From 2 Years Low (%) +44.62
Change From 2 Years High -10.610 % Change From 2 Years High (%) -79.00
5 Years Range 1.950 - 13.430 Change From 5 Years Low +0.870 % Change From 5 Years Low (%) +44.62
Change From 5 Years High -10.610 % Change From 5 Years High (%) -79.00
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Enochian Biosciences, Inc. engages in the development of genetically modified cellular and immune-therapy technologies for treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev on January 18, 2011 and is headquartered in Los Angeles, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
27 Nov 2020 2.990 3.011 2.600 2.820 309,380 -
25 Nov 2020 2.960 3.000 2.900 2.980 64,753 -
24 Nov 2020 3.060 3.060 2.840 2.970 93,494 -
23 Nov 2020 3.110 3.110 2.990 3.020 90,170 -
20 Nov 2020 3.180 3.240 3.110 3.200 22,321 -
19 Nov 2020 3.150 3.250 3.150 3.240 12,273 -
18 Nov 2020 3.190 3.300 3.150 3.230 40,636 -
17 Nov 2020 3.120 3.200 3.040 3.140 41,107 -
16 Nov 2020 3.060 3.170 3.000 3.160 81,777 -
13 Nov 2020 3.090 3.120 3.000 3.050 87,034 -
12 Nov 2020 3.067 3.140 2.990 3.060 47,324 -
11 Nov 2020 3.150 3.179 3.010 3.070 40,812 -
10 Nov 2020 3.000 3.110 2.950 3.100 95,665 -
09 Nov 2020 3.150 3.320 3.150 3.150 67,788 -
06 Nov 2020 3.040 3.130 3.040 3.050 14,150 -
05 Nov 2020 3.230 3.350 3.050 3.060 35,221 -
04 Nov 2020 3.210 3.270 3.130 3.130 26,382 -
03 Nov 2020 3.240 3.260 3.150 3.210 42,430 -
02 Nov 2020 3.190 3.247 3.110 3.160 27,559 -
30 Oct 2020 3.200 3.200 3.030 3.050 38,846 -
29 Oct 2020 3.250 3.275 3.160 3.180 25,297 -
28 Oct 2020 3.300 3.365 3.150 3.170 29,111 -
Summary
Current 2 Weeks
(13 Nov 2020 to 27 Nov 2020)
3.090 3.300 2.600 2.820 842,945 -
Previous 2 Weeks
(30 Oct 2020 to 12 Nov 2020)
3.200 3.300 2.600 3.060 436,177 -
4 Weeks from
(02 Oct 2020 to 29 Oct 2020)
3.460 3.595 2.600 3.180 815,524 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.